CCK antagonist 1
Product Specifications
UNSPSC Description
CCK antagonist 1 (compound 3d) is a CCK antagonist with IC50s of 1.1 μM and 4 μM for CCK1 and CCK2, respectively. CCK antagonist 1 can be used for research of cancer and mental disease[1].
Target Antigen
Cholecystokinin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cck-antagonist-1.html
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(CCC1=CNC2=C1C=CC=C2)NC3=C(C)N(C)N(C4=CC=CC=C4)C3=O
Molecular Weight
374.44
References & Citations
[1]Eric Lattmann, et al. Novel ureido - and amido-pyrazolone derivatives. Patent WO2004106306A1.|[2]Lattmann E, et al. Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1H-pyrazol-4-yl)-1H-indole-carboxamides as cholecystokinin antagonists. J Pharm Pharmacol. 2006 Mar;58(3):393-401.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162070/CCK-antagonist-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162070/CCK-antagonist-1-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
742116-45-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1474877 Inquire
Recombinant Borrelia garinii Aspartate--tRNA ligase (aspS), partial
Ask
View Details